Patents by Inventor Metabolex, Inc.

Metabolex, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DCC Mediated Coupling for Halofenate Manufacture
    Publication number: 20140206892
    Abstract: The present application discloses a process for the preparation of a halofenate compound of the formula (III) or a salt thereof: wherein R, X and X? are as defined herein, the process comprising contacting a compound of formula (Ia) with a compound of formula (Ib) and N,N?-dicyclohexylcarbodiimide under conditions sufficient to form the compound of formula (III).
    Type: Application
    Filed: January 18, 2013
    Publication date: July 24, 2014
    Applicant: Metabolex, Inc.
    Inventor: Metabolex, Inc.
  • GPR120 RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20130131351
    Abstract: GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
    Type: Application
    Filed: October 5, 2012
    Publication date: May 23, 2013
    Applicant: Metabolex, Inc.
    Inventor: Metabolex, Inc.
  • GPR120 RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20130109734
    Abstract: GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
    Type: Application
    Filed: October 4, 2012
    Publication date: May 2, 2013
    Applicant: Metabolex, Inc.
    Inventor: Metabolex, Inc.